Clinical Trial Update: Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study [NA]

View source ↗

Summary

A pilot study explored neoadjuvant therapy with docetaxel and ketoconazole in high-risk prostate cancer; the trial's current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Kansas City Veteran Affairs Medical Center | Conditions: Prostate Cancer | NA | Status: UNKNOWN